tenoxicam ( 20 mg/day ) and piroxicam ( 20 mg/day ) were compared in a double-blind , parallel group study over 4 weeks in 30 patients with ankylosing spondylitis .
C0031990
piroxicam
C0038013
ankylosing spondylitis